DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $373,000 | +45.7% | 10,000 | 0.0% | 0.22% | +46.7% |
Q1 2021 | $256,000 | +16.4% | 10,000 | 0.0% | 0.15% | +19.7% |
Q4 2020 | $220,000 | -38.9% | 10,000 | -50.0% | 0.13% | +5.8% |
Q3 2020 | $360,000 | +41.7% | 20,000 | +100.0% | 0.12% | -22.1% |
Q2 2020 | $254,000 | +38.0% | 10,000 | 0.0% | 0.15% | -5.5% |
Q1 2020 | $184,000 | -16.4% | 10,000 | 0.0% | 0.16% | +1.9% |
Q4 2019 | $220,000 | -61.7% | 10,000 | -75.0% | 0.16% | -58.1% |
Q3 2019 | $574,000 | -19.0% | 40,000 | -11.1% | 0.38% | -11.4% |
Q2 2019 | $709,000 | +7.6% | 45,000 | 0.0% | 0.43% | +4.4% |
Q1 2019 | $659,000 | +37.0% | 45,000 | 0.0% | 0.41% | -9.2% |
Q4 2018 | $481,000 | -30.0% | 45,000 | 0.0% | 0.46% | +2.7% |
Q3 2018 | $687,000 | +24.7% | 45,000 | 0.0% | 0.44% | +18.4% |
Q2 2018 | $551,000 | +28.1% | 45,000 | 0.0% | 0.37% | +32.2% |
Q1 2018 | $430,000 | +5.9% | 45,000 | 0.0% | 0.28% | +18.9% |
Q4 2017 | $406,000 | +56.8% | 45,000 | 0.0% | 0.24% | +77.6% |
Q3 2017 | $259,000 | +311.1% | 45,000 | +125.0% | 0.13% | +306.1% |
Q2 2017 | $63,000 | – | 20,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |